Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 14/20 | 0.53 |
| ▸ | PRSS2 | P07478 | 6/20 | 0.53 |
| ▸ | PRSS3 | P35030 | 6/20 | 0.53 |
| ▸ | C1S | P09871 | 3/20 | 0.53 |
| ▸ | F2 | P00734 | 2/20 | 0.53 |
| ▸ | PLG | P00747 | 2/20 | 0.53 |
| ▸ | GSK3B | P49841 | 2/20 | 0.51 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2869263 | 0.98 | PRSS1 (0.55) | PRSS1PRSS2PRSS3C1SF2 | |
| Isopropyl Alcohol SCHEMBL28326201 | 0.90 | PRSS1 (0.47) | PRSS1PRSS2PRSS3C1SF2 | |
| Benzamidine SCHEMBL27541129 | 0.83 | PRSS1 (0.53) | PRSS1PRSS2PRSS3C1SF2 | |
| Phenyl Ethanol SCHEMBL28326106 | 0.82 | PRSS1 (0.46) | PRSS1PRSS2PRSS3C1SF2 | |
| Hydrochloric Acid SCHEMBL28325039 | 0.82 | GSK3B (0.48) | PRSS1PRSS2PRSS3C1SF2 | |
| Benzamidine SCHEMBL6823484 | 0.82 | PRSS1 (0.68) | PRSS1PRSS2PRSS3C1SF2 | |
| Hydrochloric Acid SCHEMBL28326094 | 0.81 | PRSS1 (0.40) | PRSS1PRSS2PRSS3C1SF2 | |
| SCHEMBL26050098 | 0.80 | WDR5 (0.56) | PRSS1PRSS2PRSS3F2PLG | |
| SCHEMBL29858580 | 0.80 | GSK3B (0.51) | PRSS1GSK3B | |
| SCHEMBL2041048 | 0.80 | GSK3B (0.61) | GSK3BRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250011315-A1 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | PRISM MEDICINES, INC. | 2025-01-09 | — | — | US | disclosed |
| US-12030876-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | Ikena Oncology, Inc. (US) | 2024-07-09 | — | — | US | disclosed |
| US-12030876-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | Ikena Oncology, Inc. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20230295147-A1 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | ARYL THERAPEUTICS, INC. | 2023-09-21 | — | — | US | disclosed |
| US-20230295147-A1 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | ARYL THERAPEUTICS, INC. | 2023-09-21 | — | — | US | disclosed |
| US-20230117034-A1 | PYRAZOLOTRIAZINES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-04-20 | — | — | US | disclosed |
| US-11608329-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | Ikena Oncology, Inc. (US) | 2023-03-21 | — | — | US | disclosed |
| CN-115279741-A | 4-phenyl-N- (phenyl) thiazol-2-amine derivatives and related compounds as Aryl Hydrocarbon Receptor (AHR) agonists for the treatment of, for example, angiogenesis-related disorders or inflammatory disorders | 医肯纳肿瘤学公司 | 2022-11-01 | — | — | CN | disclosed |
| EP-4073072-A1 | PYRAZOLOTRIAZINES | Bayer Aktiengesellschaft (DE) | 2022-10-19 | — | — | EP | disclosed |
| CN-115023427-A | Pyrazolotriazines | 拜耳公司 | 2022-09-06 | — | — | CN | disclosed |
| WO-2016080791-A1 | A PLURALITY OF HOST MATERIALS AND AN ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2016-05-26 | — | — | WO | disclosed |
| WO-2015178732-A1 | MULTI-COMPONENT HOST MATERIAL AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2015-11-26 | — | — | WO | disclosed |
| WO-2015160224-A1 | MULTI-COMPONENT HOST MATERIAL AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2015-10-22 | — | — | WO | disclosed |
| WO-2015156587-A1 | MULTI-COMPONENT HOST MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2015-10-15 | — | — | WO | disclosed |
| US-8975314-B2 | Triazine derivative and ultraviolet absorber | FUJIFILM CORPORATION (JP) | 2015-03-10 | — | — | US | disclosed |
| US-8957140-B2 | Triazine derivative, ultraviolet absorber, and resin composition | FUJIFILM CORPORATION (JP) | 2015-02-17 | — | — | US | disclosed |
| US-8957140-B2 | Triazine derivative, ultraviolet absorber, and resin composition | FUJIFILM CORPORATION (JP) | 2015-02-17 | — | — | US | disclosed |
| US-20140213703-A1 | NEW TRIAZINE DERIVATIVE AND ULTRAVIOLET ABSORBER | FUJIFILM CORPORATION (JP) | 2014-07-31 | — | — | US | disclosed |
| US-20120136098-A1 | NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-05-31 | — | — | US | disclosed |
| US-20120136098-A1 | NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250011315-A1 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | AHR, ARNT, HCAR1 | PRSS1 3635/4885PRSS2 3834/4885PRSS3 3607/4885 |
| US-11608329-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | AHR, ARNT, HCAR1 | PRSS1 3635/4885PRSS2 3834/4885PRSS3 3607/4885 |
| US-20230117034-A1 | PYRAZOLOTRIAZINES | BRCA1, TPX2, CCND2 | PRSS1 375/4885PRSS2 395/4885PRSS3 366/4885 |
| US-12030876-B2 | Aryl hydrocarbon receptor (AHR) agonists and uses thereof | AHR, ARNT, HCAR1 | PRSS1 3635/4885PRSS2 3834/4885PRSS3 3607/4885 |
| US-20230295147-A1 | ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF | AHR, ARNT, HCAR1 | PRSS1 3635/4885PRSS2 3834/4885PRSS3 3607/4885 |
| US-20120136098-A1 | NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION | C1R, RPSA, H1-2 | PRSS1 2006/4885PRSS2 2119/4885PRSS3 1890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.